Drugs and Devices
The US Food and Drug Administration (FDA) announced that the indications for the MitraClip™, made by Abbott, have been expanded to include secondary mitral regurgitation.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
March 11, 2019
The authors control pulmonary artery bleeding during a thoracoscopic segment resection.
March 8, 2019
Patient Care and General Interest
The American Heart Association has released a scientific statement summarizing emerging knowledge about sensitization after heart transplant.
March 4, 2019
The complete pathologic response rate in this study is revealed to be low, lower than expected after stereotactic ablative radiotherapy (SABR) for early stage non-small cell lung cancer: only 60%. The authors suggest a combined approach (SABR plus surgery), adopted in this experimental phase 2 trial, as a possible management scheme.
March 1, 2019
Patient Care and General Interest
One of the professional golfers who qualified for this weekend’s PGA Tour event is also a two-time heart transplant recipient.
February 28, 2019
Filmed at the 2018 STS Annual Meeting in Fort Lauderdale, Florida, Douglas Wood moderates a discussion on the disparities in access to lung cancer screening.
February 22, 2019
Patient Care and General Interest
February 14, 2019
Yang and colleagues investigated the use of intestinal flaps for the reconstruction of the cervical esophagus. They reviewed 22 patients with intestinal segments used to salvage failed primary esophagus reconstruction. There was one case of flap failure.
February 8, 2019
This video demonstrates a robotic left apical and posterior segmentectomy, performed in a patient with bilateral adenocarcinoma, during which an aberrant superior pulmonary vein was incidentally discovered.
February 6, 2019
Park and colleagues evaluated the effect of neoadjuvant chemotherapy for thymic cancers, comparing postoperative outcomes and long-term survival between 102 matched pairs of patients who underwent either upfront resection or resection after neoadjuvant chemotherapy.